The myelodysplastic syndromes: towards a functional classification.
The French-American-British classification of myelodysplastic syndromes (MDS) has contributed greatly to better communication and conduct of clinical trials. However, the advent of novel cytogenetic, immunological and molecular techniques in recent years warrant some alterations to this purely morphological classification. This review aims at highlighting the advances which reflect more closely the unique biological and clinical features of various subtypes of MDS. We propose a comprehensive classification of MDS, to include the newly defined categories, as well as those not included in previous classifications, such as the therapy-induced and hereditary MDS. We hope that this classification will help in focusing attention on the biological features of MDS, the understanding of which will be crucial to combat this disease.
Mijović
A
A
Department of Haematological Medicine, King's College Hospital Denmark Hill, London, UK.
Mufti
G J
GJ
D000328:Adult; D000753:Anemia, Refractory / Q000145:classification; D000754:Anemia, Refractory, with Excess of Blasts / Q000145:classification; D000756:Anemia, Sideroblastic / Q000145:classification; D002872:Chromosome Deletion; D005260:Female; D006801:Humans; D015477:Leukemia, Myelomonocytic, Chronic / Q000145:classification / Q000209:etiology; D009190:Myelodysplastic Syndromes / Q000145:classification* / Q000209:etiology / Q000235:genetics; D010375:Pedigree